@article{b1cd90fbf24342b5afa422b7b92d4357,
title = "CLP1 links tRNA metabolism to progressive motor-neuron loss",
abstract = "CLP1 was the first mammalian RNA kinase to be identified. However, determining its in vivo function has been elusive. Here we generated kinase-dead Clp1 (Clp1K/K) mice that show a progressive loss of spinal motor neurons associated with axonal degeneration in the peripheral nerves and denervation of neuromuscular junctions, resulting in impaired motor function, muscle weakness, paralysis and fatal respiratory failure. Transgenic rescue experiments show that CLP1 functions in motor neurons. Mechanistically, loss of CLP1 activity results in accumulation of a novel set of small RNA fragments, derived from aberrant processing of tyrosine pre-transfer RNA. These tRNA fragments sensitize cells to oxidative-stress-induced p53 (also known as TRP53) activation and p53-dependent cell death. Genetic inactivation of p53 rescues Clp1K/K mice from the motor neuron loss, muscle denervation and respiratory failure. Our experiments uncover a mechanistic link between tRNA processing, formation of a new RNA species and progressive loss of lower motor neurons regulated by p53.",
author = "Toshikatsu Hanada and Stefan Weitzer and Barbara Mair and Christian Bernreuther and Wainger, {Brian J.} and Justin Ichida and Reiko Hanada and Michael Orthofer and Cronin, {Shane J.} and Vukoslav Komnenovic and Adi Minis and Fuminori Sato and Hiromitsu Mimata and Akihiko Yoshimura and Ido Tamir and Johannes Rainer and Reinhard Kofler and Avraham Yaron and Eggan, {Kevin C.} and Woolf, {Clifford J.} and Markus Glatzel and Ruth Herbst and Javier Martinez and Penninger, {Josef M.}",
note = "Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA); Austrian Ministry of Sciences; Austrian Academy of Sciences; AustroMouse network of Genome Research in Austria (GEN-AU); Apoptosis systems biology applied to cancer and AIDS (ApoSys); European Research Council Advanced Grant from the European Union; IMBA; GEN-AU (AustroMouse); Japan Society for the Promotion of Science; Astellas Foundation; National Institutes of Health (NIH) [K99NS077435-01A1]; German Research Foundation (DFG) [FG885, GRK 1459]; Landesexzellenzinitiative Hamburg (Neurodapt); Austrian Science Fund [P19223, P21667]; NIH [NS038253]We thank A. Meixner, M. Foong, T. Nakashima, H. C. Theussl, J. R. Wojciechowski, A. Bichl, the mouse pathology unit of the Universitatsklinikum Hamburg-Eppendorf, and G. P. Resch for discussions and technical support. We also thank T. Buerckstuemmer for providing the pRV-NTAP vector. J. M. P. is supported by grants from the Institute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), the Austrian Ministry of Sciences, the Austrian Academy of Sciences, AustroMouse network of Genome Research in Austria (GEN-AU), Apoptosis systems biology applied to cancer and AIDS (ApoSys) and a European Research Council Advanced Grant from the European Union. J. M., S. W. and B. M. are supported by IMBA and GEN-AU (AustroMouse). T. H. is supported by the Japan Society for the Promotion of Science and the Astellas Foundation. J. K. I. was supported by National Institutes of Health (NIH) grant K99NS077435-01A1. M. G. is supported by grants from the German Research Foundation (DFG) (FG885 and GRK 1459), the Landesexzellenzinitiative Hamburg (Neurodapt). R. H. was supported by the Austrian Science Fund (P19223, P21667). C. J. W. is supported by the NIH (NS038253).",
year = "2013",
month = mar,
day = "28",
doi = "10.1038/nature11923",
language = "الإنجليزيّة",
volume = "495",
pages = "474--480",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Research",
number = "7442",
}